Visen Pharmaceuticals Funding: $190M Raised, Series B (2021)
Visen Pharmaceuticals is based in Suzhou, China. It has raised $190M in total funding. Latest round: Series B.
Visen Pharmaceuticals funding overview
Visen Pharmaceuticals is based in Suzhou, China. Visen Pharmaceuticals has raised $190M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2021. The round record for Visen Pharmaceuticals runs through 2021; nothing later has been disclosed. Investors on record include Hongshan Capital Group (Sequoia Capital China), Qiming Venture Partners, Vivo Capital, Michael Wolff Jensen, CDG Capital, Cormorant Asset Management and 6 others. 12 distinct backers are named across the disclosed rounds.
Visen Pharmaceuticals at a glance
Total raised
$190M
Latest round
Series B
Latest round date
January 2021
Headquarters
Suzhou, China
Notable investors
Hongshan Capital Group (Sequoia Capital China), Qiming Venture Partners, Vivo Capital, Michael Wolff Jensen, CDG Capital, Cormorant Asset Management, HBM Healthcare Investments, Logos Capital
Frequently asked about Visen Pharmaceuticals funding
How much has Visen Pharmaceuticals raised?
Visen Pharmaceuticals has raised $190M in total disclosed funding across the rounds on record.
Who has invested in Visen Pharmaceuticals?
Hongshan Capital Group (Sequoia Capital China), Qiming Venture Partners, Vivo Capital, Michael Wolff Jensen, CDG Capital, Cormorant Asset Management are named among the investors backing Visen Pharmaceuticals.
What was the latest Visen Pharmaceuticals funding round?
The most recent disclosed round is a Series B, announced in January 2021.
Where is Visen Pharmaceuticals based?
Visen Pharmaceuticals is based in Suzhou, China.
When did Visen Pharmaceuticals last raise?
The last disclosed Visen Pharmaceuticals round closed in January 2021 at Series B.
We update the Visen Pharmaceuticals record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Suzhou and their backers are listed below.
